RSS-Feed abonnieren

DOI: 10.1055/s-0042-1755437
Diabetic Foot Infection Characteristics and Antibiotics Susceptibility Patterns in a Regional Hospital in Libya
Funding and Sponsorship None.

Abstract
Introduction Diabetes is a major global health problem, among the top causes of death worldwide. Diabetic foot infection (DFI) is associated with an increased risk of amputation by 155 times and a mortality rate of 57% at 5 years. This study aims to characterize DFI epidemiology in a local hospital and analyze local microbiological patterns and antibiotic susceptibility testing.
Patients and Methods This is a retrospective review of Al Jala hospital Benghazi/Libya medical records. Eligible patients were included, if they had DFI with confirmed tissue/pus samples collections was submitted to the hospital laboratory for microbiology and Antibiotics susceptibility analysis.
Results Out of 126 patients, 77 (61.1%) were men, and 49 (38.9%) were women. The mean age was 55.4 years. Incision drainage with debridement was the most common surgical procedure (77.1%). 38.88% of growth was polymicrobial. Gram-negative rods were isolated in 70.9%, and gram-positive cocci in 27.4%. The most commonly isolated bacteria were Pseudomonas aeruginosa (15.9%) and Proteus sps. (14.2%), Staphylococcus aureus (11.3%), and Escherichia coli (10.2%). Methicillin-resistant Staphylococcus aureus (MRSA) constitutes 30% of isolated S. aureus. The most common effective antibiotic for P. aeruginosa was imipenem (90%), for S. aureus was linezolid (100%), and for MRSA was linezolid, vancomycin (100%), and ciprofloxacin 88.8%. Sixty-four percent of total bacterial isolates were MDROs (gram-positive isolates 65.3%, gram-negative isolates 63.6%).
Conclusions The emergence of antibiotic-resistant bacteria is a global health concern. This study attempts to evaluate the local microbiology and antimicrobial susceptibility to tailor the treatment choice for better patient outcomes.
Compliance with Ethical Principles
The Research Ethics Board (REB) and Al Jala Hospital Surgical Department approved the study. The consent was waived, and all data were collected anonymously.
Publikationsverlauf
Artikel online veröffentlicht:
16. September 2022
© 2022. The Libyan Authority of Scientific Research and Technology and the Libyan Biotechnology Research Center. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Saeedi P, Petersohn I, Salpea P. et al; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019; 157: 107843
- 2 Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27 (05) 1047-1053
- 3 Frykberg RG. Diabetic foot ulcers: pathogenesis and management. Am Fam Physician 2002; 66 (09) 1655-1662
- 4 Uçkay I, Gariani K, Pataky Z, Lipsky BA. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab 2014; 16 (04) 305-316
- 5 Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care 2006; 29 (06) 1288-1293
- 6 Matta-Gutiérrez G, García-Morales E, García-Álvarez Y, Álvaro-Afonso FJ, Molines-Barroso RJ, Lázaro-Martínez JL. The influence of multidrug-resistant bacteria on clinical outcomes of diabetic foot ulcers: a systematic review. J Clin Med 2021; 10 (09) 1948
- 7 Lipsky BA. Bone of contention: diagnosing diabetic foot osteomyelitis. Clin Infect Dis 2008; 47 (04) 528-530
- 8 Uçkay I, Hoffmeyer P, Lew D, Pittet D. Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-the-art update. J Hosp Infect 2013; 84 (01) 5-12
- 9 Pataky Z, Vischer U. Diabetic foot disease in the elderly. Diabetes Metab 2007; 33 (Suppl. 01) S56-S65
- 10 Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Hinchliffe RJ, Lipsky BA. IWGDF Editorial Board. Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev 2020; 36 (Suppl. 01) e3266
- 11 Schaper NC, Andros G, Apelqvist J. et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012; 28 (Suppl. 01) 218-224
- 12 Lavery LA, Davis KE, Berriman SJ. et al. WHS guidelines update: diabetic foot ulcer treatment guidelines. Wound Repair Regen 2016; 24 (01) 112-126
- 13 Lipsky BA, Berendt AR, Cornia PB. et al; Infectious Diseases Society of America. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54 (12) e132-e173
- 14 Lipsky BA, Senneville É, Abbas ZG. et al; International Working Group on the Diabetic Foot (IWGDF). Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 2020; 36 (Suppl. 01) e3280
- 15 Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes 2013; 62 (03) 923-930
- 16 Ramakant P, Verma AK, Misra R. et al. Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?. Diabetologia 2011; 54 (01) 58-64
- 17 Linton C, Searle A, Hawke F, Tehan PE, Chuter V. Nature and extent of outpatient podiatry service utilisation in people with diabetes undergoing minor foot amputations: a retrospective clinical audit. J Foot Ankle Res 2021; 14 (01) 6
- 18 Paisley AN, Kalavalapalli S, Subudhi CP, Chadwick PR, Chadwick PJ, Young B. Real time presence of a microbiologist in a multidisciplinary diabetes foot clinic. Diabetes Res Clin Pract 2012; 96 (01) e1-e3
- 19 Frykberg RG, Wukich DK, Kavarthapu V, Zgonis T, Dalla Paola L. Board of the Association of Diabetic Foot Surgeons. Surgery for the diabetic foot: a key component of care. Diabetes Metab Res Rev 2020; 36 (Suppl. 01) e3251
- 20 Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118 (01) 146-155
- 21 Magiorakos AP, Srinivasan A, Carey RB. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18 (03) 268-281
- 22 Weinstein MP, Lewis II JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol 2020; 58 (03) e01864-e19
- 23 Eltaweel Mohamed, Karayem Jebril Karayem. Identification and antimicrobial susceptibility of bacterial species obtained from diabetic foot lesion. Accessed 25 June, 2022 at: https://lam.edu.ly/ar/index.php/component/content/article/92-academic-research-mag/156-m-academy
- 24 Jouhar L, Minhem M, Akl E, Rizk N, Hoballah J. Microbiological profile of diabetic foot infection in the Middle East and North Africa: a systematic review. Wounds 2019; 6 (01) 43-50
- 25 Irhuma AET, Ahmed MG, Salih K, El Houderi E. Diabetic foot in the South of Libya. Sebha Med J. 2006; 5 (01) 12-19
- 26 Sekhar S, Vyas N, Unnikrishnan M, Rodrigues G, Mukhopadhyay C. Antimicrobial susceptibility pattern in diabetic foot ulcer: a pilot study. Ann Med Health Sci Res 2014; 4 (05) 742-745
- 27 Benkhadoura M, Alswehly M, Elbarsha A. Clinical profile and surgical management of diabetic foot in Benghazi, Libya. Foot Ankle Surg 2016; 22 (01) 55-58
- 28 Rigato M, Pizzol D, Tiago A, Putoto G, Avogaro A, Fadini GP. Characteristics, prevalence, and outcomes of diabetic foot ulcers in Africa. A systemic review and meta-analysis. Diabetes Res Clin Pract 2018; 142: 63-73
- 29 Goh TC, Bajuri MYC, C. Nadarajah S, Abdul Rashid AH, Baharuddin S, Zamri KS. Clinical and bacteriological profile of diabetic foot infections in a tertiary care. J Foot Ankle Res 2020; 13 (01) 36
- 30 Son ST, Han SK, Lee TY, Namgoong S, Dhong ES. The microbiology of diabetic foot infections in Korea. J Wound Manag Res 2017; 13 (01) 8-12
- 31 Reveles KR, Duhon BM, Moore RJ, Hand EO, Howell CK. Epidemiology of methicillin-resistant Staphylococcus aureus diabetic foot infections in a large academic hospital: implications for antimicrobial Stewardship. PLoS One 2016; 11 (08) e0161658
- 32 Brown NM, Goodman AL, Horner C, Jenkins A, Brown EM. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK. JAC Antimicrob Resist 2021; 3 (01) dlaa114
- 33 Ji X, Jin P, Chu Y, Feng S, Wang P. Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection. Int J Low Extrem Wounds 2014; 13 (01) 64-71
- 34 Yan X, Song JF, Zhang L, Li X. Analysis of risk factors for multidrug-resistant organisms in diabetic foot infection. BMC Endocr Disord 2022; 22 (01) 46